News Focus
News Focus
icon url

Investor2014

10/09/24 8:09 AM

#471051 RE: ignatiusrielly35 #471050

What valuation are you expecting given the results Anavex have produced to date from 3 potentially pivotal, but strictly failed clinical trials?

Keep in mind that the analyst valuations are looking 12 months ahead with assumptions of approvals and revenue ahead - a scenario that may happen with some non zero chance later than 12 months from now.

icon url

crescentmotor

10/09/24 9:58 AM

#471069 RE: ignatiusrielly35 #471050

There is actual trading manipulation.



Of course there is also trading manipulation--I understand that very well and often post about it. The stock market invented the word "shady".

we need, namely an EMA application, followed hopefully by its acceptance. But that is neither fatal



If there is no EMA application, it may not be fatal but I predict it would be a near death experience for AVXL and its shareholders.